In 2009, researchers conducted the first-ever trial on cancer immunotherapy using mRNA-based vaccines in human subjects with metastatic melanoma. The results of

In 2009, researchers conducted the first-ever trial on cancer immunotherapy using mRNA-based vaccines in human subjects with metastatic melanoma. The results of the trial showed an increase in the number of vaccine-directed T cells against melanoma (Weide et al., 2009). https://the-dna-universe.com/2021/04/15/the-history-of-mrna-applications/ https://the-dna-universe.com/2021/04/15/the-history-of-mrna-...